| # | Country | Total Patents | |
|---|---|---|---|
| #1 | United States | 8 | |
| #2 | WIPO (World Intellectual Property Organization) | 6 | |
| #3 | EPO (European Patent Office) | 5 | |
| #4 | Australia | 4 | |
| #5 | Canada | 4 | |
| #6 | Hong Kong | 1 |
| # | Industry | |
|---|---|---|
| #1 | Pharmaceuticals | |
| #2 | Biotechnology | |
| #3 | Measurement |
| # | Technology | |
|---|---|---|
| #1 | Medical preparations | |
| #2 | Microorganisms | |
| #3 | Analysing materials | |
| #4 | Therapeutic chemical compounds | |
| #5 | Peptides |
| # | Name | Total Patents |
|---|---|---|
| #1 | Cooper Mark J | 27 |
| #2 | Costello Maureen | 11 |
| #3 | Pasumarthy Murali K | 11 |
| #4 | Kowalczyk Tomasz H | 10 |
| #5 | Padegimas Linas | 6 |
| #6 | Kowalczyk Thomasz H | 6 |
| #7 | Pasumarthy Murali Krishna | 5 |
| #8 | Perales Jose C | 5 |
| #9 | Casal Hector L | 5 |
| #10 | Noronha Glenn | 4 |
| Publication | Filing date | Title |
|---|---|---|
| EP3717024A2 | Gene therapy for ocular improvement | |
| WO2011017313A1 | Method of administering non-viral nucleic acid vectors to the eye | |
| WO2009036280A1 | Long-term in vivo transgene expression | |
| CA2665620A1 | Codon optimized cftr | |
| US2003078230A1 | Lyophilizable and enhanced compacted nucleic acids | |
| WO0192580A2 | Lyophilizable and enhanced compacted nucleic acids | |
| US6281005B1 | Automated nucleic acid compaction device |